Switch theme
Sign up to access all valuation multiples
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
1994
20.7K+
LTM Revenue $9.7B
LTM EBITDA $3.4B
$21.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Bausch Health has a last 12-month revenue of $9.7B and a last 12-month EBITDA of $3.4B.
In the most recent fiscal year, Bausch Health achieved revenue of $6.7B and an EBITDA of $2.0B.
Bausch Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Bausch Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $6.1B | $6.7B | XXX | XXX | XXX |
| Gross Profit | $4.0B | $4.3B | XXX | XXX | XXX |
| Gross Margin | 66% | 64% | XXX | XXX | XXX |
| EBITDA | $1.5B | $2.0B | XXX | XXX | XXX |
| EBITDA Margin | 25% | 29% | XXX | XXX | XXX |
| Net Profit | -$157M | -$414M | XXX | XXX | XXX |
| Net Margin | -3% | -6% | XXX | XXX | XXX |
| Net Debt | $14.1B | $15.0B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Bausch Health's stock price is CAD 6 (or $4).
Bausch Health has current market cap of CAD 2.2B (or $1.6B), and EV of CAD 30.6B (or $21.4B).
See Bausch Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $21.4B | $1.6B | XXX | XXX | XXX | XXX | $4.10 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Bausch Health has market cap of $1.6B and EV of $21.4B.
Bausch Health's trades at 2.2x LTM EV/Revenue multiple, and 6.4x LTM EBITDA.
Analysts estimate Bausch Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Bausch Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $21.4B | XXX | XXX | XXX |
| EV/Revenue | 3.2x | XXX | XXX | XXX |
| EV/EBITDA | 10.8x | XXX | XXX | XXX |
| P/E | -48.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 24.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBausch Health's NTM/LTM revenue growth is 3%
Bausch Health's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Bausch Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Bausch Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Bausch Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 28% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 32% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 52% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bausch Health acquired XXX companies to date.
Last acquisition by Bausch Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Bausch Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Bausch Health founded? | Bausch Health was founded in 1994. |
| Where is Bausch Health headquartered? | Bausch Health is headquartered in Canada. |
| How many employees does Bausch Health have? | As of today, Bausch Health has 20.7K+ employees. |
| Who is the CEO of Bausch Health? | Bausch Health's CEO is Mr. Thomas J. Appio. |
| Is Bausch Health publicy listed? | Yes, Bausch Health is a public company listed on TSE. |
| What is the stock symbol of Bausch Health? | Bausch Health trades under BHC ticker. |
| When did Bausch Health go public? | Bausch Health went public in 1987. |
| Who are competitors of Bausch Health? | Similar companies to Bausch Health include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Bausch Health? | Bausch Health's current market cap is $1.6B |
| What is the current revenue of Bausch Health? | Bausch Health's last 12-month revenue is $9.7B. |
| What is the current EBITDA of Bausch Health? | Bausch Health's last 12-month EBITDA is $3.4B. |
| What is the current EV/Revenue multiple of Bausch Health? | Current revenue multiple of Bausch Health is 2.2x. |
| What is the current EV/EBITDA multiple of Bausch Health? | Current EBITDA multiple of Bausch Health is 6.4x. |
| What is the current revenue growth of Bausch Health? | Bausch Health revenue growth between 2023 and 2024 was 10%. |
| Is Bausch Health profitable? | Yes, Bausch Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
